a-66

A66 is a specific and effective p110α inhibitor(IC50=32 nM).

TRIA-662 (Nicotinamide Chloromethylate) is a niacin metabolite excreted via the urinary system.

β-catenin modulator IIa-661 is a small molecule inhibitor of the Wnt pathway with antitumour activity.

SH-E4A-66 is a C2-COUPLr (COvalent Protein Ligators) featuring a carbazole skeleton, which does not include heterogeneous cysteine-reactive warheads such as acrylamide and chloroacetamide. This compound effectively couples with EML4-ALK (EC50=1.5 μM) and inhibits the kinase activity of EML4-ALK (IC50=2.3 µM).

PHA-665752 is an effective, specific and ATP-competitive c-Met inhibitor (IC50: 9 nM), >50-fold selectivity for c-Met than STKs or RTKs.

LL-37, Human acetate is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity.

Compound FL0153, with CAS No. 278788-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0153 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound FL0181, with CAS No. 158063-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound FL0181 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12177, with CAS No. 2923-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12177 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13401, with CAS No. 26475-66-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13401 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13714, with CAS No. 14268-66-7, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13714 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13871, with CAS No. 673-66-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13871 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr14116, with CAS No. 51-66-1, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr14116 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

2-(3-HYDROXYPROPYL)BENZIMIDAZOLE, with CAS No. 2403-66-9, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-(3-HYDROXYPROPYL)BENZIMIDAZOLE provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0282, with CAS No. 579-66-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0282 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0329, with CAS No. 66521-66-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0329 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound PDK0357, with CAS No. 7506-66-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound PDK0357 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Lithocholic acid (3α-Hydroxy-5β-cholanic acid) is a toxic secondary bile acid, They were FXR antagonists (IC50=0.7, 1.4 μM), EphA2 antagonists (IC50=48, 66 μM) and EphB4 antagonists (IC50=141 μM). Lithocholic acid can promote intrahepatic cholestasis and promote tumorigenesis. Lithocholic acid is a cleanser that dissolves fat for absorption and is itself absorbed.

1,2-Diphenoxyethane is composed of two phenoxy groups connected by ethane and is widely used in biochemical experiments and drug synthesis research.

Compound EN300-21005, with CAS No. 5785-66-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound EN300-21005 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr12999, with CAS No. 852180-66-6, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr12999 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13107, with CAS No. 550347-66-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13107 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13291, with CAS No. 219865-66-4, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13291 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Compound Fr13321, with CAS No. 65032-66-8, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. Compound Fr13321 provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.